Introduction {#sec1}
============

Kefir is produced by milk fermentation using either traditional kefir grains, which are a complex mixture of microorganisms, mainly yeasts, lactic acid and acetic bacteria, casein and polysaccharides, or industrial mother cultures prepared from grains, or commercial freeze-dried kefir starter cultures.^[@ref1]^ Traditionally, kefir consumption has been linked with health-promoting effects such as anticarcinogenic, antimicrobial, and immunomodulatory activities, mainly attributed to the probiotic microflora and to its metabolites.^[@ref2],[@ref3]^ Recently, peptide profiling in kefir revealed sixteen peptides originating from milk proteins with established bioactivity.^[@ref4]^

Casein phosphopeptides (CPPs) are a subgroup of bioactive milk peptides consisting of multiphosphorylated peptides, which can be endogenously present in milk,^[@ref5]^ or released from precursor proteins by digestive enzymes,^[@ref6]^ or by microbial enzymes during fermentation.^[@ref7]^ CPPs can efficiently bind and solubilize bivalent metal ions such as Ca^2+^, thus enhancing the absorption of minerals in the gastrointestinal tract,^[@ref8]^ improving tooth enamel remineralization in the oral cavity, and buffering the plaque pH.^[@ref9]^ Indeed, it was reported that β-casein~1--25~4P (P = phosphate group) and α-casein~59--79~5P can bind 24 and 17 mol of Ca^2+^ and phosphate, respectively. Besides, CPPs have even higher affinity to zinc, iron, and copper.^[@ref8]^ Calcium binding strongly correlates with the presence of phosphorylated serine residues, which are necessary to enhance the calcium absorption from the small intestine.^[@ref10]^ Dephosphorylated peptides, in contrast, do not bind calcium.^[@ref11]^ Calcium dissolution by phosphopeptides is due to the calcium-binding capacity of the phosphoserine (pS) residues, which form amorphous calcium-phosphate nanoclusters.^[@ref12]^ Furthermore, the phosphorylated sequences make CPPs more resistant to gastrointestinal enzymatic digestion so that they are suitable carriers for metal ions.^[@ref13]^

Fermentation is expected to promote the formation of CPPs during kefir production compared to unfermented milk. It is therefore important to include CPPs with their potential effects on remineralization and calcium bioavailability in the evaluation of health-promoting effects of kefir. Based on these considerations, our goal was to identify multiphosphorylated peptides in kefir. Although liquid chromatography coupled to tandem mass spectrometry analysis (LC--MS/MS) or matrix-assisted desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) can efficiently achieve peptide profiling in milk and milk products,^[@ref5],[@ref14]−[@ref16]^ multiphosphorylated peptides are negatively discriminated in a complex peptide matrix. During LC--MS/MS analysis, the negative charge of the phosphate group leads to low ionization efficiency^[@ref17],[@ref18]^ and ion suppression by nonphosphorylated peptides.^[@ref19]^ For example, the list of 257 peptides previously identified in kefir included only mono- or diphosphorylated peptides besides nonphosphorylated sequences,^[@ref4]^ although multiphosphorylated peptides were also expected to occur. Among the latter species, those containing the motif pSpSpSEE (pS = phosphoserine) are the most capable of calcium binding and have, therefore, particular biofunctional relevance.^[@ref9]^ Enrichment of phosphopeptides has been achieved, for example, by immobilized metal-affinity chromatography, metal oxide-affinity chromatography with TiO~2~, ZrO~2~, Fe~2~O~3~, or Al~2~O~3~,^[@ref20]^ or by hydroxyapatite.^[@ref21]^ The present study used hydroxyapatite enrichment prior to MS-based phosphopeptide profiling to improve the coverage of multiphosphorylated peptides.

Although CPPs mainly act as anticariogenic agents in the oral cavity, they could also improve mineral resorption, if CPP structures are actually present in the gastrointestinal tract. The extensive degradation of bioactive milk peptides during digestion is well known, but gastrointestinal enzymes can also form novel bioactive sequences.^[@ref22]−[@ref25]^ Even though CPPs are more resistant to enzymatic hydrolysis than unphosphorylated peptides, subsequent formation and degradation of CPPs during pancreatin treatment has been observed.^[@ref9]^ Therefore, our second purpose was to monitor the formation and degradation of kefir phosphorylated peptides during simulated gastrointestinal digestion.

Results and Discussion {#sec2}
======================

Profiling of Phosphopeptides in Kefir by MALDI-TOF-MS {#sec2.1}
-----------------------------------------------------

To screen for phosphopeptides in kefir, peptides were isolated and phosphopeptides were enriched using hydroxyapatite extraction,^[@ref26]^ which is based on the interaction of the phosphate groups with Ca^2+^ ions of the hydroxyapatite.^[@ref27]^ This method is particularly suitable to cover multiphosphorylated peptides because the binding affinity increases with the number of phosphorylation sites.^[@ref21]^ The phosphopeptide fraction was then analyzed by MALDI-TOF-MS, which has been successfully applied before to identify (multi-)phosphorylated peptides in milk.^[@ref5]^

To confirm that the detected peptides actually were phosphopeptides, MALDI-TOF-MS analysis of the samples was repeated after enzymatic dephosphorylation.^[@ref17]^[Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} shows a representative MALDI-TOF-MS spectrum after hydroxyapatite enrichment before (a) and after (b) dephosphorylation. Signals that were no longer detectable after the hydrolysis step were assigned to a phosphopeptide structure and subjected to further analysis. The disappearance of the phosphopeptide signal was accompanied by a new signal with a mass shift of −80 Da or a multiple thereof corresponding to an unphosphorylated peptide formed by the loss of one or more HPO~3~^--^ groups. The resulting signal pairs are marked by boxes of identical color in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}. In total, 27 signal pairs were detected (please note that [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} highlights predominant signals only).

![MALDI-TOF mass spectra (positive ion mode) of the phosphopeptide fraction of kefir obtained by hydroxyapatite enrichment (a) before and (b) after (reflected spectrum) dephosphorylation. Boxes of identical color mark the peptide pairs exhibiting a mass shift of −80 Da or a multiple thereof indicating the presence of a phosphopeptide.](ao-2018-03105g_0001){#fig1}

Identification of Phosphopeptides by UHPLC--ESI--MS/MS {#sec2.2}
------------------------------------------------------

In the next step, the amino acid sequences of the detected phosphopeptides were identified by ultrahigh-performance liquid chromatography coupled to electrospray ionization tandem mass spectrometry (UHPLC--ESI--MS/MS). For this purpose, enhanced product ion mass spectra were recorded using the *m/z* values of the dephosphorylated peptides detected by MALDI-TOF-MS as the parent ion ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). LC--ESI--QTrap-MS/MS analysis determined 18 dephosphopeptide structures. Because the quality of the LC--ESI--QTrap-MS/MS product-ion spectra of nine dephosphopeptides was not sufficient, corresponding structures were definitely identified by LC--ESI--QTOF-MS/MS analysis ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, peptides no. 7, 12, 15, 19, 23, 24, 25, 26, and 27). [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"} displays the resulting MS/MS spectrum of the multiphosphorylated peptide β-casein~7--37~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, no. 26), with the relevant sequence scheme showing the amino acid bond cleavage leading to the experimentally detected fragments. As expected, y-ion residues predominated in the LC--ESI--QTOF-MS/MS spectrum compared to b-ions.^[@ref28]^ The multiphosphopeptide β-casein~7--37~ is a breakdown product of β-casein, which contains five phosphorylated serine units and the sequence motif pSpSpSEE, which is most active in binding minerals.^[@ref8]^

![Tandem mass spectrum of peptide β-casein~7--37~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, no. 26) after dephosphorylation applying a precursor mass of *m/z* 877.4 (quadruple charge). The b- and y-ion series are single- to triple-charged. Potential phosphoserine residues reported in the literature are underlined.](ao-2018-03105g_0002){#fig2}

###### Identification of Phosphopeptides in Kefir[a](#t1fn1){ref-type="table-fn"}

  no.   \[M + H\]^+^ phosphorylated                                                 \[M + H\]^+^ dephosphorylated   parent protein   position   sequence                                                         phosphorylation degree
  ----- --------------------------------------------------------------------------- ------------------------------- ---------------- ---------- ---------------------------------------------------------------- ------------------------
  1     1040.4[c](#t1fn3){ref-type="table-fn"}                                      960.4                           κ-casein         143--151   T.VATLED[S]{.ul}PE.V                                             1
  2     1089.5[c](#t1fn3){ref-type="table-fn"}                                      1009.5                          β-casein         30--37     K.IEKFQ[S]{.ul}EE.Q                                              1
  3     1139.5[c](#t1fn3){ref-type="table-fn"}                                      1059.5                          α~s1~-casein     115--123   N.[S]{.ul}AEERLHSM.K                                             1
  4     1216.6[b](#t1fn2){ref-type="table-fn"}                                      1136.7                          β-casein         28--36     N.KKIEKFQ[S]{.ul}E.E                                             1
  5     1217.5[b](#t1fn2){ref-type="table-fn"}^,^[c](#t1fn3){ref-type="table-fn"}   1137.6                          β-casein         29--37     K.KIEKFQ[S]{.ul}EE.Q                                             1
  6     1228.6[c](#t1fn3){ref-type="table-fn"}                                      1148.5                          κ-casein         141--151   E.STVATLED[S]{.ul}PE.V                                           1
  7     1296.6[b](#t1fn2){ref-type="table-fn"}                                      1136.5                          β-casein         10--20     P.GEIVE[S]{.ul}L[SSS]{.ul}E.E                                    2
  8     1340.6[b](#t1fn2){ref-type="table-fn"}                                      1260.5                          GlyCAM-1         32--42     E.DL[S]{.ul}KEP[S]{.ul}I[S]{.ul}RE.D                             1
  9     1345.6[b](#t1fn2){ref-type="table-fn"}^,^[c](#t1fn3){ref-type="table-fn"}   1265.6                          β-casein         10--21     P.GEIVE[S]{.ul}L[SSS]{.ul}EE.S                                   1
  10    1393.8[b](#t1fn2){ref-type="table-fn"}                                      1313.8                          GlyCAM-1         43--53     E.DLI[S]{.ul}KEQIVIR.S                                           1
  11    1505.9[b](#t1fn2){ref-type="table-fn"}                                      1265.8                          β-casein         10--21     P.GEIVE[S]{.ul}L[SSS]{.ul}EE.S                                   3
  12    1684.7[b](#t1fn2){ref-type="table-fn"}                                      1604.7                          α~s1~-casein     64--78     E.[S]{.ul}I[SSS]{.ul}EEIVPNSVEQ.K                                1
  13    1702.1[b](#t1fn2){ref-type="table-fn"}                                      1461.8                          β-casein         8--21      N.VPGEIVE[S]{.ul}L[SSS]{.ul}EE.S                                 3
  14    1541.8[b](#t1fn2){ref-type="table-fn"}                                      1461.8                          GlyCAM-1         22--33     Q.FIRNLQI[S]{.ul}NEDL.S                                          1
  15    1728.8[b](#t1fn2){ref-type="table-fn"}^,^[c](#t1fn3){ref-type="table-fn"}   1648.6                          β-casein         25--37     T.RINKKIEKFQ[S]{.ul}EE.Q                                         1
  16    1781.9[b](#t1fn2){ref-type="table-fn"}                                      1461.5                          β-casein         8--21      N.VPGEIVE[S]{.ul}L[SSS]{.ul}EE.S                                 4
  17    1786.6[c](#t1fn3){ref-type="table-fn"}                                      1626.7                          α~s1~-casein     41--55     L.[S]{.ul}KDIG[S]{.ul}E[S]{.ul}TEDQAME.D                         2
  18    1895.6[b](#t1fn2){ref-type="table-fn"}                                      1575.8                          β-casein         7--21      L.NVPGEIVE[S]{.ul}L[SSS]{.ul}EE.S                                4
  19    2029.9[b](#t1fn2){ref-type="table-fn"}                                      1950.0                          β-casein         22--37     E.SITRINKKIEKFQ[S]{.ul}EE.Q                                      1
  20    2196.8[b](#t1fn2){ref-type="table-fn"}                                      1876.9                          β-casein         7--24      L.NVPGEIVE[S]{.ul}L[SSS]{.ul}EESIT.R                             4
  22    2579.7[b](#t1fn2){ref-type="table-fn"}                                      2260.0                          β-casein         7--27      L.NVPGEIVE[S]{.ul}L[SSS]{.ul}EESITRIN.K                          4
  22    2665.1[b](#t1fn2){ref-type="table-fn"}                                      2345.2                          β-casein         1--21      RELEELNVPGEIVE[S]{.ul}L[SSS]{.ul}EE.S                            4
  23    2989.1[b](#t1fn2){ref-type="table-fn"}                                      2669.4                          β-casein         15--37     E.[S]{.ul}L[SSS]{.ul}EESITRINKKIEKFQ[S]{.ul}EE.Q                 4
  24    3068.9[b](#t1fn2){ref-type="table-fn"}                                      2669.2                          β-casein         15--37     E.[S]{.ul}L[SSS]{.ul}EESITRINKKIEKFQ[S]{.ul}EE.Q                 5
  25    3808.4[b](#t1fn2){ref-type="table-fn"}                                      3488.7                          α~s2~-casein     49--79     N.EEEYSIG[SSS]{.ul}EE[S]{.ul}AEVATEEVKITVDDKHYQ.K                4
  26    3906.5[b](#t1fn2){ref-type="table-fn"}                                      3506.6                          β-casein         7--37      L.NVPGEIVE[S]{.ul}L[SSS]{.ul}EESITRINKKIEKFQ[S]{.ul}EE.Q         5
  27    4635.9[b](#t1fn2){ref-type="table-fn"}                                      4236.1                          β-casein         7--43      L.NVPGEIVE[S]{.ul}L[SSS]{.ul}EESITRINKKIEKFQ[S]{.ul}EEQQQTED.E   5

Phosphopeptide profiling was achieved by MALDI-TOF-MS using two complementary methods (A and B) after hydroxyapatite enrichment, which were performed before and after dephosphorylation to assess the phosphorylation degree. The sequences identified by subsequent UHPLC--ESI--MS/MS analysis after enrichment with hydroxyapatite and enzymatic dephosphorylation are shown in the single-letter code and peptide masses are given in Da. Phosphorylated serine residues reported in the literature are underlined ([S]{.ul}) and cleavage sites are indicated by dots.

Detected using method A.

Detected using method B.

Sequence structures could thus be attributed to 26 phosphopeptides detected by MALDI-TOF-MS ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Additionally, chromatographic separation of the dephosphorylated peptides revealed two different dephosphopeptides with *m/z* 1461 eluting at different retention times, which had not been distinguished by MALDI-TOF-MS. Subsequently, enhanced product-ion mass spectra identified β-casein~8--21~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, peptide no. 13) and glycosylation-dependent adhesion molecule (GlyCAM)-1~22--33~ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, no. 14). In total, 27 phosphorylated peptides could be identified ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Finally, MALDI-TOF-MS detected one peptide with *m/z* 3161.6 and the putative phosphorylation degree of 4, but the quality of UHPLC--ESI--MS and MS/MS spectra was not sufficient for structural elucidation.

The mass of the detected phosphopeptides ranged between 1040 and 4636 Da; 14 out of 27 identified peptides were multiphosphorylated, with two to five pS residues. The present results confirmed that hydroxyapatite enrichment combined with the use of a suitable buffer is highly efficient for the analysis of multiphosphorylated peptides.^[@ref21]^ As shown in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, also partially phosphorylated peptides were identified in kefir, such as peptide GlyCAM-1~32--42~1P (no. 8) and α~s1~-casein~41--55~2P (no. 17), both containing three possible phosphorylation sites. Additionally, β-casein~10--21~1P and 3P, β-casein~10--20~2P, β-casein~8--21~3P, and α~s1~-casein~64--78~1P were present, all with four possible phosphorylation sites, and the β-casein~15--37~4P with five possible phosphorylation sites. Nonphosphorylated or partially phosphorylated caseins have been detected in the mammary gland.^[@ref29]^ In the presence of cations, such as Mg^2+^, Ca^2+^, or Mn^2+^, casein kinase catalyzes the phosphorylation of partially phosphorylated caseins in the lactating mammary gland using adenosine triphosphate as a phosphate donor.^[@ref30]^ Furthermore, caseins could be partially dephosphorylated due to the activity of alkaline phosphatase, which is associated with a high somatic cell count.^[@ref31]^

The identified phosphopeptides are breakdown products of the main milk proteins, such as α~s1~-casein (34% of the peptide fraction in milk), β-casein (25%), κ-casein (9%), α~s2~-casein (8%), and GlyCAM-1 ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). The latter protein is a small phosphoglycoprotein, also known as proteose peptone component 3 (PP3) or lactophorin, which is the main component of the proteose peptone fraction of bovine milk (approximately 25%).^[@ref32]^ GlyCAM-1 contains 135 amino acids and five pSs (S~29~, S~34~, S~38~, S~40~, and S~46~), as shown in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}. Phosphopeptides found in kefir derived mainly from β-casein (64% of the identified phosphopeptides), followed by α~s1~-casein (11%) and GlyCAM-1 (11%), κ-casein (7%), and lastly, α~s2~-casein with one fragment ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). These results confirmed β-casein as the preferential substrate for microbial protein degradation during the transformation of milk to kefir,^[@ref4],[@ref7]^ even though α~s1~-casein is the most abundant milk protein.

![Amino acid sequences of milk proteins identified as parent proteins of phosphopeptides in kefir in the single letter code. Arrows indicate the released phosphopeptides (see [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Phosphoserine residues are marked in red.](ao-2018-03105g_0003){#fig3}

Potential Bioactivity of the Identified Kefir Phosphopeptides {#sec2.3}
-------------------------------------------------------------

Caseins feature several possible phosphorylation sites, namely 13 in α~s2~-casein, 9 in α~s1~-casein, 5 in β-casein, and 2 in κ-casein, which often occur in clusters ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). In particular, the high-polar acidic motif pSpSpSEE of CPPs shows predominant bioactivity such as mineral binding, which is responsible for the remineralization of tooth enamel, calcium absorption, and calcium bioavailability.^[@ref8],[@ref33]^ In our experiments, 12 peptide sequences deriving from the breakdown of β-casein (8) and α~s2~-casein (1) contained the mineral-binding motif ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}).

Besides the typical cluster sequence, other peptide factors are also important for the intestinal uptake of minerals, such as the total negative charge, the total number of amino acids, the phosphorylation degree, and the amino acid composition next to the phosphorylated region.^[@ref34],[@ref35]^ In fact, β-casein~1--25~ phosphopeptide was more active in promoting mineral uptake by human tumor cells HT29 than α~s1~-casein~59--79~ phosphopeptide,^[@ref36]^ even though α~s1~-casein, which is rich in serine/threonine, usually generates peptides with stronger mineral-binding capacity than β- and κ-casein.^[@ref37]^ Specific secondary structure motifs and the aggregation degree of CPPs in the presence of bivalent cations are required to enhance mineral absorption.^[@ref36]^ Previous studies have demonstrated conformational changes of the peptide backbone during calcium binding for β-casein~1--25~ (loop-type structure of the residue R~1~ to E~4~, followed by three β-turns of residues V~8~ to E~11~, pS~17~ to E~20~, and E~21~ to T~24~)^[@ref38]^ and for α~s1~-casein~59--79~ phosphopeptides (loop-type structure of the residue E~61~ to pS~67~ and β-turn of residue P~73~ to V~76~).^[@ref39]^ Despite the presence of the acidic motif, calcium uptake was not evoked when the typical loop-like structure (N-terminal region) in β-casein~1--25~ was absent, whereas the lack of the C-terminal residues did not affect the activity.^[@ref36]^ Thus, only the phosphopeptide β-casein~1--21~ found in kefir would effectively enhance the absorption of calcium in the intestine. Nevertheless, studies on the enhancement of mineral absorption by CPPs are controversial.^[@ref40]^ In fact, a positive effect on bone mineralization has been shown for β-casein~29--41~ in vitro, although the peptide carries only one phosphorylated serine.^[@ref41]^ Three phosphopeptides ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, no. 2, 4, and 5) of the present study contain a similar amino acid sequence.

Identification of Phosphopeptides after Gastrointestinal Digestion {#sec2.4}
------------------------------------------------------------------

During gastrointestinal digestion, CPPs could not only be degraded but also newly released from their parent proteins. Thus, the present study subjected kefir to simulated gastrointestinal digestion and tested for phosphopeptides as described above.

After the simulated gastrointestinal digestion of kefir, MALDI-TOF-MS analysis identified eight peptide pairs before and after enzymatic dephosphorylation that indicated the presence of phosphopeptides, including seven single-phosphorylated and one double-phosphorylated peptides. Because of the poor quality of the enhanced product-ion spectra of putative phosphopeptides generated by UHPLC--ESI--MS/MS and LC--ESI--QTOF-MS/MS, only four phosphopeptides were identified ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}), including two α~s2~-casein breakdown products (α~s2~-casein~124--133~ and α~s2~-casein~137--146~), as well as one β-casein- and one κ-casein fragment (β-casein~30--40~ and κ-casein~147--161~). The low number of identified peptides may reflect either the low concentration of CPPs in the digest and/or their low ionization efficiency. κ-Casein~147--161~ had been detected before in a casein-derived byproduct after tryptic hydrolysis before and after simulated gastrointestinal digestion.^[@ref42]^ Additionally, Picariello et al. found β-casein~30--40~ in a peptide mixture, which survived the gastrointestinal digestion of casein in vitro.^[@ref43]^ Although the list of phosphopeptides after simulated gastrointestinal digest is not comprehensive, these results indicate that phosphopeptides can be released from precursor proteins and peptides in the gastrointestinal tract after the ingestion of kefir. It has to be considered, however, that brush border enzymes at the intestinal microvilli including proteases and phosphatases are not covered by the applied model of gastrointestinal digestion and may further modify the phosphopeptide profile after digestion in vivo. Still, a certain stability of CPPs during digestion has been recently demonstrated when phosphorylated casein fragments were detected in the human plasma after the consumption of cheese.^[@ref44]^ Furthermore, increased calcium-binding capacity compared to goat milk was observed for goat kefir after in vitro digestion but not directly after production, indicating that CPPs were released during the simulated digest.^[@ref45]^

###### Identification of Kefir Phosphopeptides after Simulated Gastrointestinal Digestion[a](#t2fn1){ref-type="table-fn"}

  no.   \[M + H\]^+^ phosphorylated   \[M + H\]^+^ dephosphorylated   parent protein   position   sequence                       phosphorylation degree
  ----- ----------------------------- ------------------------------- ---------------- ---------- ------------------------------ ------------------------
  1     1218.6                        1138.5                          α~s2~-casein     137--146   K.KTVDME[S]{.ul}TEV.F          1
  2     1352.6                        1192.5                          α~s2~-casein     124--133   L.NREQL[S]{.ul}T[S]{.ul}EE.N   2
  3     1473.7                        1393.6                          β-casein         30--40     K.IEKFQ[S]{.ul}EEQQQ.T         1
  4     1735.7                        1655.7                          κ-casein         147--161   L.EDSPEVIE[S]{.ul}PPEINT.V     1

The phosphopeptide profile was obtained after hydroxyapatite enrichment by MALDI-TOF-MS using method B. Peptide sequences determined by UHPLC--ESI--QTrap-MS/MS are shown in the single-letter code and peptides masses are given in Da. Phosphorylated serine residues reported in the literature are underlined ([S]{.ul}) and cleavage sites are indicated by dots.

Conclusions {#sec3}
===========

The present study demonstrated that multiphosphorylated casein peptides are present in kefir. Because CPPs are strong chelators for bivalent metal ions, the detected phosphopeptides may thus exert anticariogenic activity. Moreover, kefir-derived phosphorylated peptides were detected after digestion in vitro, indicating that they may also influence mineral absorption. Thus, the discussion of various health-promoting effects of kefir should also consider CPPs. Further studies are required, however, to determine the role of kefir-derived phosphopeptides in the oral cavity or in the gastrointestinal tract for mineral absorption in vivo.

Materials and Methods {#sec4}
=====================

Materials and Reagents {#sec4.1}
----------------------

Hydroxyapatite (CHT Ceramic Type I, 40 μm) was purchased from Bio-Rad (Munich, Germany). Formic acid (LC--MS grade), potassium chloride, 85% o-phosphoric acid, ammonium hydrogen carbonate, 4-chloro-α-cyanocinnamic acid, and 2,5-dihydroxybenzoic acid were obtained from Sigma-Aldrich (Taufkirchen, Germany). Acetonitrile (LC--MS grade) was purchased from Honeywell Fluka (Seelze, Germany) and 1,4-dithiothreitol was purchased from Carl Roth (Karlsruhe, Germany). Tris(hydroxymethyl)aminomethane hydrochloride and ammonia (25%) were purchased from Acros Organics (Geel, Belgium) and urea was purchased from Merck Millipore (Darmstadt, Germany). Alkaline phosphatase (1500 U, grade I) from calf intestine was purchased from Roche Diagnostics (Mannheim, Germany). Purified water was taken from a Milli-Q system (Merck Chemicals, Darmstadt, Germany).

Three different kefir batches of the same brand were purchased from a local supermarket. The kefir was industrially produced from pasteurized and homogenized low-fat organic cow milk (1.5%) using a complex culture of yeast and lactic acid bacteria.

Sample Preparation {#sec4.2}
------------------

After centrifuging the kefir sample at 3850 rpm and 4 °C, for 30 min, to separate caseins and other insoluble components, the supernatant was passed through a sterile membrane filter (0.22 μm; Roth, Karlsruhe, Germany). The water-soluble fraction was divided into aliquots of 5 mL and frozen at −80 °C until use. For UHPLC--ESI--MS/MS, the aliquots were filtered once more using centrifugal filter units with 10 kDa molecular weight cutoff (Merck, Darmstadt, Germany) at 12 000 rpm and 4 °C, for 90 min, and stored at −80 °C until use.

Phosphopeptide Enrichment by Hydroxyapatite Extraction {#sec4.3}
------------------------------------------------------

Phosphopeptide enrichment was carried out according to an established protocol^[@ref26]^ with some modifications. Briefly, the sample was incubated with hydroxyapatite for 15 min at room temperature in a thermomixer (Eppendorf, Hamburg, Germany) at 1000 rpm. Then, it was centrifuged at 7500 rpm for 3 min. Identical centrifugation conditions were applied for the washing steps. Then, 4 mg of the hydroxyapatite--phosphopeptide mixture was dissolved in 240 μL of 5% phosphoric acid solution to solubilize the phosphopeptides. Stage Tip extraction using C18 Empore Disk with 2--200 μL pipet tips (Eppendorf, Hamburg, Germany) was performed as described before.^[@ref23]^ The peptide fraction was eluted with 10 μL of acetonitrile/0.1% formic acid in aqueous solution (60:40). The samples were extracted in quadruplicate, and the eluates were combined to a final volume of 40 μL and analyzed by MALDI-TOF-MS either directly or after dephosphorylation.

Dephosphorylation of the Phosphopeptide Fraction {#sec4.4}
------------------------------------------------

Prior to dephosphorylation, samples were vacuum-dried (SpeedVac, Thermo Electron, Dreieich, Germany) and reconstituted with 50 μL of 0.4% ammonium bicarbonate solution (pH 9.0, adjusted with 25% ammonia).^[@ref26]^ After adding 1 μL of alkaline phosphatase, the sample was incubated at 37 °C, for 1 h, in a thermomixer at 550 rpm. Following enzymatic hydrolysis, the sample was cooled on ice, purified once again by Stage Tip as described above, and analyzed by MALDI-TOF-MS and UHPLC--ESI--MS/MS.

In Vitro Digestion of Kefir {#sec4.5}
---------------------------

Kefir was digested in vitro as described previously.^[@ref23]^ Briefly, the samples were treated with α-amylase and mucin for 5 min, at 37 °C (oral phase). After adjusting the pH to 2--3, pepsin was added and incubated for 2 h, at 37 °C (gastric phase). Finally, pancreatin and bile extract were added, the pH was adjusted to 7 and digestion was continued for 2 h, at 37 °C (duodenal phase). As discussed before,^[@ref23]^ this protocol differs only minimally from the standardized protocol,^[@ref46]^ mainly by the concentration of the inorganic salts and the absence of organic additives. The standardized protocol had been applied before to analyze the peptide release from low-fat caprine kefir.^[@ref47]^ After enrichment by hydroxyapatite extraction as described above, phosphopeptides were identified by MALDI-TOF-MS before and after dephosphorylation.

MALDI-TOF-MS Analysis {#sec4.6}
---------------------

For MALDI-TOF-MS analysis, samples were mixed 1:1 with a matrix. The matrix consisted either of (A) 10 mg of 2.5-dihydroxybenzoic acid in 1 mL of acetonitrile/2.4% o-phosphoric acid aqueous solution (50:50) or (B) 5 mg 2,5-dihydroxybenzoic acid in 1 mL of acetonitrile/0.1% trifluoroacetic acid (60:40). Method B detected some additional peptides, mainly in the lower molecular range. Samples (0.7 μL) were spotted onto a MALDI target (Bruker Daltonik, Bremen, Germany) and air-dried. Mass calibration was achieved by a mixture (1:5) of Bruker peptide standard solution II and the matrix. Analysis was performed on a Bruker Autoflex III MALDI-TOF mass spectrometer equipped with nitrogen laser in the positive reflector mode measuring a mass range of 600--5000 Da. The ions were time-delayed (140 ns) and accelerated at a voltage of 20 kV. Each measurement summed up 200--250 individual spectra generated manually from five different spots.

UHPLC--ESI--QTrap-MS/MS Analysis {#sec4.7}
--------------------------------

UHPLC--ESI--QTrap-MS/MS analyses were performed on a Dionex Ultimate 3000 RS system (ThermoFisher Scientific, Idstein, Germany) coupled to a 4000 QTrap mass spectrometer (AB Sciex, Darmstadt, Germany) with an ESI source. Chromatographic separation was achieved with an Acquity BEH 300 C18 column (100 mm × 2.1 mm, 1.7 μm; Waters, Eschborn, Germany) at 30 °C. The mobile phase consisted of 0.1% formic acid aqueous solution (eluent A) and acetonitrile (eluent B) and the separation was conducted applying the gradient −6.0--5.0 min 5% B, 5.0--25.0 min 5--42.5% B, 25.0--25.5 min 42.5--95% B, and 25.5--30.0 min 95% B with a flow rate of 0.3 mL/min. The sample volume was 20 μL. To determine the retention time and charge state of the phosphopeptides previously detected by MALDI-TOF-MS, measurements were carried out in the positive enhanced mass spectra mode with the *m/z* 400--1200 and 1100--2000 ranges. The ion source voltage was set to 5000 V and declustering potential to 50 V. To obtain fragmentation spectra of the phosphopeptides, tandem mass spectra were acquired in the enhanced product-ion mode, with collision energies in the range of 20--30 V and collision energy spread of 10 V. Nitrogen was used for collision-induced dissociation. Acquisition of spectra with insufficient fragmentation was repeated with 40 V collision energy and 10 V collision energy spread. Analyst software version 1.6.3 was used for data acquisition and processing.

UHPLC--ESI--QTOF-MS Analysis {#sec4.8}
----------------------------

Phosphopeptides were analyzed by microUHPLC (Ultimate 3200 RS, ThermoFisher Scientific, Idstein, Germany) interfaced with an ESI--QTOF mass spectrometer (6600 TripleTOF, AB Sciex, Darmstadt, Germany). A Triart C18 column (100 × 0.5 mm, 3 μm; YMC Europe, Dinslaken, Germany) equipped with a precolumn containing the same material, operating with a flow rate of 30 μL/min and 35 °C column temperature was chosen for chromatographic separation. The mobile phase consisted of 0.1% formic solution (eluent A) and acetonitrile containing 0.1% formic acid (eluent B) and the separation was conducted applying the gradient 15.0 min 2% B, 5.0 min 2% B, 55.0 min 42.5% B, 55.5 min 95% B, and 65.0 min 95% B. The sample volume was 4 μL. Ion spray voltage was set to 5200 V and declustering potential to 80 V. Nitrogen was used as the collision gas in the MS/MS experiments for peptide sequencing. Raw data were processed using PeakView (version 2.2, AB Sciex, Darmstadt, Germany) and Protein Pilot (version 5.0, AB Sciex, Darmstadt, Germany).

Database Search {#sec4.9}
---------------

For structure identification, MS/MS spectra were searched against the UniProt database^[@ref48]^ by mMass (Open Source Mass Spectrometry Tool, version 5.5)^[@ref49]^ and Protein Pilot software. Because peptide sequences randomly generated by kefir microflora were scarce in the online databases, we manually searched the phosphopeptide sequences of known bovine phosphorylated proteins to achieve an unambiguous identification. The amino acid sequences of phosphopeptides were obtained by de novo peptide sequencing. First, a bovine milk peptide database was generated by an ion fragment calculator in mMass software including precursor, position, and mass of all possible peptides derived from α~s1~- (P02662), α~s2~- (P02663), β- (P02666), and κ-casein (P02668), serum albumin (P02769), GlyCAM-1 (P80195), and osteopontin (P31096) without enzyme restriction. Peak picking was applied for signals with signal-to-noise ratios of four or higher. The peptides were manually identified by comparing the *m/z* values of product ions determined in the experimental spectra with the theoretical *m/z* values of product ions of all possible sequences in the database with the same *m/z* value of the precursor ion. Mass tolerance was set to 0.2 Da for precursor-ion spectra and 0.2 and 0.02 Da for product-ion spectra. Only peptides identified in all three kefir batches were included.
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CPP

:   casein-phosphopeptides

ESI

:   electrospray ionization

GlyCAM

:   glycosylation-dependent adhesion molecule

MALDI-TOF-MS

:   matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

MS/MS

:   tandem mass spectrometry

P

:   phosphate group

pS

:   phosphoserine

UHPLC

:   ultrahigh-performance liquid chromatography
